BioAge Labs, Inc.

BIOANASDAQHealthcareDrug Manufacturers - Specialty & Generic

$5.35- (-)1Y +3.28%

As of Oct 15, 2026 close

Market cap: $239.89M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $5.04$25.96
Volume (live): -
Avg. volume (3M): 802.63K

BioAge Labs, Inc. (BIOA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for BioAge Labs, Inc. stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Buy

Based on 10 unique analysts

(12 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$35.63

+636.16% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest BIOA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Sep 29, 2026	Samantha Semenkow	Citi	Maintains	Buy	$21.00
Sep 14, 2026	Joseph Stringer	Needham	Maintains	Buy	$35.00
Sep 9, 2026	Adam Walsh	Roth MKM	Reiterates	Buy	$25.00
Sep 5, 2026	Edmund Ingham	Forbes	Initiates Coverage	Buy	-
Aug 7, 2026	Michael Ulz	Morgan Stanley	Maintains	Hold	$23.00 → $20.00 −3.00 (−13.0%)
Aug 6, 2026	Andy Hsieh	William Blair	Reiterates	Hold	-
Aug 6, 2026	Yasmeen Rahimi	Piper Sandler	Initiates Coverage	Buy	$73.00
Aug 6, 2026	Jay Olson	Oppenheimer	Maintains	Buy	$50.00
Aug 5, 2026	Yasmeen Rahimi	Piper Sandler	Reiterates	Buy	$73.00
Aug 5, 2026	Thomas Shrader	BTIG	Maintains	Buy	$40.00
Aug 3, 2026	Thomas Shrader	BTIG	Maintains	Buy	$40.00
Jul 31, 2026	Roger Song	Jefferies	Maintains	Buy	$62.00 → $21.00 −41.00 (−66.1%)

Samantha Semenkow

Citi

BuyMaintains

$21.00

Sep 29

Joseph Stringer

Needham

BuyMaintains

$35.00

Sep 14

Adam Walsh

Roth MKM

BuyReiterates

$25.00

Sep 9

Edmund Ingham

Forbes

BuyInitiates Coverage

Sep 5

Michael Ulz

Morgan Stanley

HoldMaintains

$23.00 → $20.00

Aug 7

Andy Hsieh

William Blair

HoldReiterates

Aug 6

Yasmeen Rahimi

Piper Sandler

BuyInitiates Coverage

$73.00

Aug 6

Jay Olson

Oppenheimer

BuyMaintains

$50.00

Aug 6

Yasmeen Rahimi

Piper Sandler

BuyReiterates

$73.00

Aug 5

Thomas Shrader

BTIG

BuyMaintains

$40.00

Aug 5

Thomas Shrader

BTIG

BuyMaintains

$40.00

Aug 3

Roger Song

Jefferies

BuyMaintains

$62.00 → $21.00

Jul 31

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 29, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for BIOA?

The analyst consensus rating for BIOA is Buy, based on the latest ratings from 10 analysts over the last 90 days.

What is the average price target for BIOA?

The average 12-month price target for BIOA is $35.63, representing an upside of 636.2% from the Oct 16, 2026 close of $4.84.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.